Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


A panacea for the Greek pharma tragedy

This article was originally published in Scrip

Executive Summary

Greece’s significant financial crisis is doubtless turning into a tragedy for patients and pharmaceutical companies alike. Recent moves by the government to enforce lower prices and subsequent threats by drug manufacturers (among them Leo Pharma, Novo Nordisk and Norgine) either of non-compliance or potential withdrawal of products could be the precursor to litigation. However, it may be possible to salvage the situation, impose the price cuts and still stay within the confines of EU law.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts